Stay updated on Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest updates to the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe website has been updated to version v2.10.3, with the removal of the section on 'Helpful Links Provided by Cantargia AB FDA Recalls, Market Withdrawals, and Safety Alerts' from the previous version v2.10.2.SummaryDifference0.5%
- Check17 days agoChange DetectedThe website has added new content, while the FDA Safety Alerts and Recalls section has been removed.SummaryDifference0.2%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check38 days agoChange DetectedDifference0.3%
- Check45 days agoChange DetectedDifference0.3%
- Check46 days agoChange DetectedDifference0.3%
Stay in the know with updates to Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.